Nelarabine is indicated for the treatment of patients with<\/strong> Nelarabine<\/a> is Generic Name for the trade name drug Atriance,<\/strong> manufactured by Novartis Pharmaceuticals. It is approved in August 2008 by the FDA. The product is available in packs of 6.<\/p>\n If Atriance (nelarabine<\/a>) Injection\u00a0<\/strong>are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN. For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query. To receive comprehensive support, please call us at +91 9891 296 838 (Mr. Tarun) \/ +91 9811 747 774 (Mr. Neeraj).<\/p>\n Note:<\/strong><\/em> NEWS \/ UPDATES<\/strong><\/p>\n Atriance contains nelarabine<\/strong> which belongs to a group of medicines known as antineoplastic agents, used in chemotherapy to kill some types of cancer cells. Atriance is used to treat patients with:<\/p>\n If you have any questions about your illness, talk to your doctor<\/p>\n
\nT-cell acute lymphoblastic leukaemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. Due to the small patient populations in these disease settings, the information to support these indications is based on limited data.\u00a0Source content :\u00a0www.accessdata.fda.gov<\/a><\/p>\nHow can 1 go about obtaining Atriance Inection?<\/h4>\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.<\/em><\/p>\n\n
Atriance (nelarabine) 5 mg\/ml solution<\/h2>\n
\n